NASDAQ : CLOV
Clover Health Investments, Corp. — Financial statements
Healthcare · Healthcare Plans · United States
Last price 4.31 USD (Nov 2, 2026, 4:00 PM EST) · Market cap 2.29B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Premiums & Annuity Revenue | 2.45B | 1.89B | 1.34B | 1.24B | 1.18B | 688.79M |
| Gain (Loss) on Sale of Investments | 572.00K | 979.00K | 13.00K | -4.71M | 8.95M | -53.00K |
| Non-Insurance Activities Revenue | 667.64M | |||||
| Other Revenue | 28.39M | 30.80M | 25.77M | 24.75M | 11.95M | 5.00M |
| Total Revenue | 2.48B | 1.92B | 1.37B | 1.26B | 1.20B | 1.36B |
| Policy Benefits | 2.02B | 1.57B | 1.01B | 1.00B | 993.07M | 1.55B |
| Depreciation & Amortization | 1.91M | 1.69M | 1.33M | 2.51M | 1.19M | 1.25M |
| Selling, General & Administrative | 332.42M | 317.93M | 290.81M | 324.02M | 367.98M | 349.01M |
| Other Operating Expenses | -800.00K | -800.00K | 70.00K | 191.00K | ||
| Total Operating Expenses | 2.49B | 2.01B | 1.42B | 1.45B | 1.48B | 2.00B |
| Operating Income | -18.36M | -85.53M | -45.93M | -184.29M | -277.45M | -636.99M |
| Interest Expense | -7.00K | -1.36M | -16.91M | |||
| Other Non Operating Income (Expenses) | -1.00K | -20.00K | -50.00K | -86.00K | 900.00K | 66.15M |
| EBT Excluding Unusual Items | -18.36M | -85.55M | -45.98M | -184.38M | -277.91M | -587.76M |
| Merger & Restructuring Charges | -288.00K | -9.82M | ||||
| Impairment of Goodwill | -11.70M | |||||
| Asset Writedown | -4.25M | |||||
| Other Unusual Items | 23.33M | |||||
| Pretax Income | -18.36M | -85.55M | -46.27M | -210.15M | -254.58M | -587.76M |
| Earnings From Continuing Ops. | -18.36M | -85.55M | -46.27M | -210.15M | -254.58M | -587.76M |
| Earnings From Discontinued Ops. | 3.26M | -3.21M | -84.98M | |||
| Net Income | -18.36M | -85.55M | -43.01M | -213.36M | -339.57M | -587.76M |
| Net Income to Common | -18.36M | -85.55M | -43.01M | -213.36M | -339.57M | -587.76M |
| Shares Outstanding (Basic) | 519.45M | 511.97M | 490.02M | 482.18M | 476.24M | 412.92M |
| Shares Outstanding (Diluted) | 519.45M | 511.97M | 490.02M | 482.18M | 476.24M | 412.92M |
| EPS (Basic) | -0.04 | -0.17 | -0.09 | -0.44 | -0.71 | -1.42 |
| EPS (Diluted) | -0.04 | -0.17 | -0.09 | -0.44 | -0.71 | -1.42 |
| Free Cash Flow | 74.21M | -68.98M | 33.29M | -145.25M | -208.39M | -283.05M |
| Free Cash Flow Per Share | 0.14 | -0.14 | 0.07 | -0.30 | -0.44 | -0.69 |
| Operating Margin | -0.74% | -4.45% | -3.35% | -14.59% | -23.13% | -46.79% |
| Profit Margin | -0.74% | -4.45% | -3.14% | -16.89% | -28.31% | -43.17% |
| Free Cash Flow Margin | 3.00% | -3.59% | 2.43% | -11.50% | -17.38% | -20.79% |
| EBITDA | -17.96M | -85.34M | -45.80M | -182.78M | -276.26M | -635.75M |
| EBITDA Margin | -0.73% | -4.44% | -3.34% | -14.47% | -23.04% | -46.70% |
| D&A For EBITDA | 405.00K | 186.00K | 131.00K | 1.51M | 1.19M | 1.25M |
| EBIT | -18.36M | -85.53M | -45.93M | -184.29M | -277.45M | -636.99M |
| EBIT Margin | -0.74% | -4.45% | -3.35% | -14.59% | -23.13% | -46.79% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Investments in Debt Securities | 199.91M | 199.66M | 216.06M | 121.00M | 138.11M | 175.94M |
| Investments in Equity & Preferred Securities | 3.90M | 3.90M | ||||
| Other Investments | 44.26M | 41.95M | 27.01M | 119.82M | 230.97M | 315.29M |
| Total Investments | 248.08M | 245.52M | 243.07M | 240.82M | 369.08M | 491.23M |
| Cash & Equivalents | 198.84M | 78.30M | 194.54M | 116.41M | 103.79M | 299.97M |
| Other Receivables | 202.74M | 158.74M | 92.79M | 86.24M | 167.54M | 109.42M |
| Property, Plant & Equipment | 7.23M | 6.38M | 5.31M | 5.08M | 9.78M | 7.65M |
| Goodwill | 11.75M | 1.24M | ||||
| Other Intangible Assets | 2.99M | 2.99M | 2.99M | 2.99M | 8.25M | 2.99M |
| Other Current Assets | 39.61M | 28.86M | 28.78M | 105.50M | 122.69M | 27.87M |
| Other Long-Term Assets | 20.84M | 20.22M | 13.26M | 13.63M | 15.73M | 10.43M |
| Total Assets | 720.33M | 541.01M | 580.74M | 570.67M | 808.62M | 950.80M |
| Accounts Payable | 35.41M | 36.21M | 34.56M | 37.18M | 32.45M | 28.13M |
| Accrued Expenses | 31.16M | 16.04M | 19.09M | 20.95M | 25.53M | 17.47M |
| Insurance & Annuity Liabilities | 7.24M | 110.63M | ||||
| Unpaid Claims | 250.89M | 153.25M | 156.40M | 137.10M | 141.95M | 138.60M |
| Current Portion of Leases | 1.57M | 1.83M | 3.06M | |||
| Long-Term Debt | 19.94M | |||||
| Long-Term Leases | 1.72M | 4.03M | 4.83M | |||
| Other Current Liabilities | 5.88M | 1.75M | 3.47M | 65.88M | 222.52M | 74.74M |
| Other Long-Term Liabilities | 20.74M | 21.76M | 26.08M | 23.16M | 16.19M | 14.10M |
| Total Liabilities | 344.07M | 232.31M | 239.60M | 284.28M | 451.73M | 411.49M |
| Common Stock | 52.00K | 52.00K | 50.00K | 49.00K | 46.00K | 46.00K |
| Additional Paid-In Capital | 2.71B | 2.68B | 2.58B | 2.46B | 2.32B | 2.15B |
| Retained Earnings | -2.23B | -2.29B | -2.20B | -2.16B | -1.95B | -1.62B |
| Treasury Stock | -95.87M | -86.19M | -30.99M | -12.73M | -6.51M | -147.00K |
| Comprehensive Income & Other | -1.55M | 528.00K | -1.58M | -2.37M | -9.37M | -1.93M |
| Total Common Equity | 376.26M | 308.70M | 341.14M | 286.39M | 356.89M | 535.41M |
| Minority Interest | 3.90M | |||||
| Shareholders' Equity | 376.26M | 308.70M | 341.14M | 286.39M | 356.89M | 539.32M |
| Total Liabilities & Equity | 720.33M | 541.01M | 580.74M | 570.67M | 808.62M | 950.80M |
| Filing Date Shares Outstanding | 531.16M | 524.67M | 510.91M | 495.29M | 479.55M | 473.26M |
| Total Common Shares Outstanding | 529.15M | 519.04M | 503.53M | 489.05M | 478.39M | 470.84M |
| Total Debt | 3.30M | 5.86M | 27.83M | |||
| Net Cash (Debt) | 198.84M | 75.00M | 194.54M | 116.41M | 97.93M | 272.14M |
| Net Cash Per Share | 0.38 | 0.15 | 0.40 | 0.24 | 0.21 | 0.66 |
| Book Value Per Share | 0.71 | 0.59 | 0.68 | 0.59 | 0.75 | 1.14 |
| Tangible Book Value | 373.27M | 305.71M | 338.15M | 283.40M | 336.89M | 531.18M |
| Tangible Book Value Per Share | 0.71 | 0.59 | 0.67 | 0.58 | 0.70 | 1.13 |
| Machinery | 148.00K | 148.00K | 148.00K | 324.00K | 148.00K | |
| Leasehold Improvements | 3.04M | 3.04M | 3.04M | 3.04M | 3.04M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -18.36M | -85.55M | -43.01M | -213.36M | -339.57M | -587.76M |
| Depreciation & Amortization | 405.00K | 186.00K | 131.00K | 1.51M | 1.19M | 1.25M |
| Other Amortization | 1.50M | 1.50M | 1.20M | 1.00M | 30.00K | 13.72M |
| Gain (Loss) on Sale of Investments | -572.00K | -979.00K | -13.00K | 4.71M | -8.95M | 53.00K |
| Stock-Based Compensation | 72.38M | 103.66M | 114.33M | 140.93M | 164.31M | 163.72M |
| Change in Accounts Receivable | -71.39M | -65.95M | -6.55M | 4.75M | -8.03M | -9.39M |
| Reinsurance Recoverable | -96.00K | |||||
| Change in Accounts Payable | 1.46M | 1.65M | -2.62M | 4.74M | 7.63M | 5.31M |
| Change in Insurance Reserves / Liabilities | 111.23M | -3.15M | 19.30M | -294.00K | 1.08M | 36.95M |
| Change in Other Net Operating Assets | -17.60M | -16.75M | 2.73M | 16.09M | -3.04M | 49.24M |
| Other Operating Activities | -2.02M | -1.55M | -3.04M | -11.17M | -119.25M | 44.68M |
| Operating Cash Flow | 77.03M | -66.93M | 34.84M | -144.66M | -203.93M | -282.33M |
| Capital Expenditures | -2.83M | -2.04M | -1.56M | -584.00K | -4.47M | -723.00K |
| Cash Acquisitions | -16.45M | |||||
| Investment in Securities | -42.70M | 6.12M | 2.12M | 140.60M | 116.05M | -434.72M |
| Investing Cash Flow | -45.52M | 4.08M | 565.00K | 140.01M | 95.13M | -435.45M |
| Total Debt Repaid | -30.93M | |||||
| Net Debt Issued (Repaid) | -30.93M | |||||
| Issuance of Common Stock | 3.13M | 1.81M | 902.00K | 1.15M | 1.40M | 956.55M |
| Repurchases of Common Stock | -24.45M | -55.20M | -18.26M | -6.22M | -6.36M | -147.00K |
| Other Financing Activities | -85.00K | |||||
| Financing Cash Flow | -21.32M | -53.38M | -17.36M | -5.07M | -4.96M | 925.39M |
| Net Cash Flow | 10.19M | -116.24M | 18.05M | -9.72M | -113.75M | 207.62M |
| Free Cash Flow | 74.21M | -68.98M | 33.29M | -145.25M | -208.39M | -283.05M |
| Free Cash Flow Margin | 3.00% | -3.59% | 2.43% | -11.50% | -17.38% | -20.79% |
| Free Cash Flow Per Share | 0.14 | -0.14 | 0.07 | -0.30 | -0.44 | -0.69 |
| Levered Free Cash Flow | 69.05M | -37.40M | 200.78M | 68.75M | -21.71M | -354.93M |
| Unlevered Free Cash Flow | 69.05M | -37.40M | 200.78M | 68.75M | -20.89M | -358.08M |
| Cash Interest Paid | 1.68M | |||||
| Change in Working Capital | 23.70M | -84.20M | 12.86M | 25.29M | -2.36M | 82.01M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.32B | 1.21B | 1.58B | 464.29M | 444.25M | 1.76B |
| Enterprise Value | 2.12B | 1.02B | 1.29B | 170.23M | 87.61M | 1.59B |
| PS Ratio | 0.92 | 0.63 | 1.15 | 0.37 | 0.37 | 1.29 |
| PB Ratio | 6.06 | 3.93 | 4.63 | 1.62 | 1.25 | 3.26 |
| P/FCF Ratio | 30.85 | 47.42 | ||||
| P/OCF Ratio | 29.72 | 45.30 | ||||
| EV/Sales Ratio | 0.84 | 0.53 | 0.94 | 0.14 | 0.07 | 1.17 |
| EV/FCF Ratio | 28.17 | 38.88 | ||||
| Debt / Equity Ratio | 0.01 | 0.02 | 0.05 | |||
| Net Debt / Equity Ratio | -0.53 | -0.24 | -0.57 | -0.41 | -0.27 | -0.51 |
| Net Debt / EBITDA Ratio | 11.07 | 0.88 | 4.25 | 0.64 | 0.35 | 0.43 |
| Net Debt / FCF Ratio | -2.68 | 1.09 | -5.84 | 0.80 | 0.47 | 0.96 |
| Quick Ratio | 1.38 | 1.34 | 1.47 | 1.24 | 1.16 | 1.95 |
| Current Ratio | 1.50 | 1.47 | 1.61 | 1.64 | 1.45 | 2.02 |
| Asset Turnover | 3.82 | 3.43 | 2.38 | 1.83 | 1.36 | 2.23 |
| Return on Equity (ROE) | -5.10% | -26.33% | -14.74% | -65.34% | -56.81% | -314.42% |
| Return on Assets (ROA) | -1.77% | -9.53% | -4.99% | -16.70% | -19.71% | -65.37% |
| Earnings Yield | -0.94% | -7.05% | -2.73% | -45.95% | -76.44% | -33.42% |
| FCF Yield | 3.24% | -5.68% | 2.11% | -31.28% | -46.91% | -16.09% |
| Buyback Yield / Dilution | -3.75% | -4.48% | -1.63% | -1.25% | -15.33% | -365.57% |